Influenza Vaccine Industry Research Report 2023

Influenza Vaccine Industry Research Report 2023


Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Highlights

The global Influenza Vaccine market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Influenza Vaccine main players include CSL, GSK, Sanofi Pasteur, Mylan, Hulan Bio, AstraZeneca, CCBIO, etc., totally accounting for about 95% of market. North America is the largest market of Influenza Vaccine, with a share over 55%. As for the types of products, it can be divided into Trivalent Influenza Vaccine and Quadrivalent Influenza Vaccine. The most common product is Quadrivalent Influenza Vaccine, with a share over 95%. In terms of applications, it is widely used in For Children (6 months to 3 years) and For Adults and Children over 3 years. The most application is in Adults and Children over 3 years, with a share over 73%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Vaccine.
The Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Influenza Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

CSL
GSK
Sanofi Pasteur
Mylan
Hulan Bio
AstraZeneca
CCBIO

Product Type Insights

Global markets are presented by Influenza Vaccine type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Influenza Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Influenza Vaccine segment by Type

Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Influenza Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Influenza Vaccine market.
Influenza Vaccine segment by Application

For Children (6 months to 3 years)
For Adults and Children over 3 years

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Influenza Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Influenza Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Influenza Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Influenza Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Influenza Vaccine Market Size (2018-2029) & (US$ Million)
2.2.2 Global Influenza Vaccine Sales (2018-2029)
2.2.3 Global Influenza Vaccine Market Average Price (2018-2029)
2.3 Influenza Vaccine by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
2.4 Influenza Vaccine by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 For Children (6 months to 3 years)
2.4.3 For Adults and Children over 3 years
3 Market Competitive Landscape by Manufacturers
3.1 Global Influenza Vaccine Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Influenza Vaccine Sales (M Doses) of Manufacturers (2018-2023)
3.3 Global Influenza Vaccine Revenue of Manufacturers (2018-2023)
3.4 Global Influenza Vaccine Average Price by Manufacturers (2018-2023)
3.5 Global Influenza Vaccine Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Influenza Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Influenza Vaccine, Product Type & Application
3.8 Global Manufacturers of Influenza Vaccine, Date of Enter into This Industry
3.9 Global Influenza Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 CSL
4.1.1 CSL Company Information
4.1.2 CSL Business Overview
4.1.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.1.4 CSL Influenza Vaccine Product Portfolio
4.1.5 CSL Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.2.4 GSK Influenza Vaccine Product Portfolio
4.2.5 GSK Recent Developments
4.3 Sanofi Pasteur
4.3.1 Sanofi Pasteur Company Information
4.3.2 Sanofi Pasteur Business Overview
4.3.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Sanofi Pasteur Influenza Vaccine Product Portfolio
4.3.5 Sanofi Pasteur Recent Developments
4.4 Mylan
4.4.1 Mylan Company Information
4.4.2 Mylan Business Overview
4.4.3 Mylan Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Mylan Influenza Vaccine Product Portfolio
4.4.5 Mylan Recent Developments
4.5 Hulan Bio
4.5.1 Hulan Bio Company Information
4.5.2 Hulan Bio Business Overview
4.5.3 Hulan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hulan Bio Influenza Vaccine Product Portfolio
6.5.5 Hulan Bio Recent Developments
4.6 AstraZeneca
4.6.1 AstraZeneca Company Information
4.6.2 AstraZeneca Business Overview
4.6.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.6.4 AstraZeneca Influenza Vaccine Product Portfolio
4.6.5 AstraZeneca Recent Developments
4.7 CCBIO
4.7.1 CCBIO Company Information
4.7.2 CCBIO Business Overview
4.7.3 CCBIO Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.7.4 CCBIO Influenza Vaccine Product Portfolio
4.7.5 CCBIO Recent Developments
5 Global Influenza Vaccine Market Scenario by Region
5.1 Global Influenza Vaccine Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Influenza Vaccine Sales by Region: 2018-2029
5.2.1 Global Influenza Vaccine Sales by Region: 2018-2023
5.2.2 Global Influenza Vaccine Sales by Region: 2024-2029
5.3 Global Influenza Vaccine Revenue by Region: 2018-2029
5.3.1 Global Influenza Vaccine Revenue by Region: 2018-2023
5.3.2 Global Influenza Vaccine Revenue by Region: 2024-2029
5.4 North America Influenza Vaccine Market Facts & Figures by Country
5.4.1 North America Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Influenza Vaccine Sales by Country (2018-2029)
5.4.3 North America Influenza Vaccine Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Influenza Vaccine Market Facts & Figures by Country
5.5.1 Europe Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Influenza Vaccine Sales by Country (2018-2029)
5.5.3 Europe Influenza Vaccine Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Influenza Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Influenza Vaccine Sales by Country (2018-2029)
5.6.3 Asia Pacific Influenza Vaccine Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Influenza Vaccine Market Facts & Figures by Country
5.7.1 Latin America Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Influenza Vaccine Sales by Country (2018-2029)
5.7.3 Latin America Influenza Vaccine Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Influenza Vaccine Sales by Country (2018-2029)
5.8.3 Middle East and Africa Influenza Vaccine Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Influenza Vaccine Sales by Type (2018-2029)
6.1.1 Global Influenza Vaccine Sales by Type (2018-2029) & (M Doses)
6.1.2 Global Influenza Vaccine Sales Market Share by Type (2018-2029)
6.2 Global Influenza Vaccine Revenue by Type (2018-2029)
6.2.1 Global Influenza Vaccine Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Influenza Vaccine Revenue Market Share by Type (2018-2029)
6.3 Global Influenza Vaccine Price by Type (2018-2029)
7 Segment by Application
7.1 Global Influenza Vaccine Sales by Application (2018-2029)
7.1.1 Global Influenza Vaccine Sales by Application (2018-2029) & (M Doses)
7.1.2 Global Influenza Vaccine Sales Market Share by Application (2018-2029)
7.2 Global Influenza Vaccine Revenue by Application (2018-2029)
6.2.1 Global Influenza Vaccine Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Influenza Vaccine Revenue Market Share by Application (2018-2029)
7.3 Global Influenza Vaccine Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Influenza Vaccine Value Chain Analysis
8.1.1 Influenza Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Influenza Vaccine Production Mode & Process
8.2 Influenza Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Influenza Vaccine Distributors
8.2.3 Influenza Vaccine Customers
9 Global Influenza Vaccine Analyzing Market Dynamics
9.1 Influenza Vaccine Industry Trends
9.2 Influenza Vaccine Industry Drivers
9.3 Influenza Vaccine Industry Opportunities and Challenges
9.4 Influenza Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Influenza Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Influenza Vaccine Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Influenza Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Influenza Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Influenza Vaccine Average Price (USD/Doses) of Manufacturers (2018-2023)
Table 11. Global Influenza Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Influenza Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Influenza Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. CSL Company Information
Table 17. CSL Business Overview
Table 18. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 19. CSL Influenza Vaccine Product Portfolio
Table 20. CSL Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 24. GSK Influenza Vaccine Product Portfolio
Table 25. GSK Recent Developments
Table 26. Sanofi Pasteur Company Information
Table 27. Sanofi Pasteur Business Overview
Table 28. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 29. Sanofi Pasteur Influenza Vaccine Product Portfolio
Table 30. Sanofi Pasteur Recent Developments
Table 31. Mylan Company Information
Table 32. Mylan Business Overview
Table 33. Mylan Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 34. Mylan Influenza Vaccine Product Portfolio
Table 35. Mylan Recent Developments
Table 36. Hulan Bio Company Information
Table 37. Hulan Bio Business Overview
Table 38. Hulan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 39. Hulan Bio Influenza Vaccine Product Portfolio
Table 40. Hulan Bio Recent Developments
Table 41. AstraZeneca Company Information
Table 42. AstraZeneca Business Overview
Table 43. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 44. AstraZeneca Influenza Vaccine Product Portfolio
Table 45. AstraZeneca Recent Developments
Table 46. CCBIO Company Information
Table 47. CCBIO Business Overview
Table 48. CCBIO Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 49. CCBIO Influenza Vaccine Product Portfolio
Table 50. CCBIO Recent Developments
Table 51. Global Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 52. Global Influenza Vaccine Sales by Region (2018-2023) & (M Doses)
Table 53. Global Influenza Vaccine Sales Market Share by Region (2018-2023)
Table 54. Global Influenza Vaccine Sales by Region (2024-2029) & (M Doses)
Table 55. Global Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 56. Global Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 57. Global Influenza Vaccine Revenue Market Share by Region (2018-2023)
Table 58. Global Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 59. Global Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 60. North America Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. North America Influenza Vaccine Sales by Country (2018-2023) & (M Doses)
Table 62. North America Influenza Vaccine Sales by Country (2024-2029) & (M Doses)
Table 63. North America Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 64. North America Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 65. Europe Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Europe Influenza Vaccine Sales by Country (2018-2023) & (M Doses)
Table 67. Europe Influenza Vaccine Sales by Country (2024-2029) & (M Doses)
Table 68. Europe Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 69. Europe Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 70. Asia Pacific Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Asia Pacific Influenza Vaccine Sales by Country (2018-2023) & (M Doses)
Table 72. Asia Pacific Influenza Vaccine Sales by Country (2024-2029) & (M Doses)
Table 73. Asia Pacific Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 74. Asia Pacific Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 75. Latin America Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Latin America Influenza Vaccine Sales by Country (2018-2023) & (M Doses)
Table 77. Latin America Influenza Vaccine Sales by Country (2024-2029) & (M Doses)
Table 78. Latin America Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 79. Latin America Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 80. Middle East and Africa Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Middle East and Africa Influenza Vaccine Sales by Country (2018-2023) & (M Doses)
Table 82. Middle East and Africa Influenza Vaccine Sales by Country (2024-2029) & (M Doses)
Table 83. Middle East and Africa Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 84. Middle East and Africa Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 85. Global Influenza Vaccine Sales by Type (2018-2023) & (M Doses)
Table 86. Global Influenza Vaccine Sales by Type (2024-2029) & (M Doses)
Table 87. Global Influenza Vaccine Sales Market Share by Type (2018-2023)
Table 88. Global Influenza Vaccine Sales Market Share by Type (2024-2029)
Table 89. Global Influenza Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 90. Global Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 91. Global Influenza Vaccine Revenue Market Share by Type (2018-2023)
Table 92. Global Influenza Vaccine Revenue Market Share by Type (2024-2029)
Table 93. Global Influenza Vaccine Price by Type (2018-2023) & (USD/Doses)
Table 94. Global Influenza Vaccine Price by Type (2024-2029) & (USD/Doses)
Table 95. Global Influenza Vaccine Sales by Application (2018-2023) & (M Doses)
Table 96. Global Influenza Vaccine Sales by Application (2024-2029) & (M Doses)
Table 97. Global Influenza Vaccine Sales Market Share by Application (2018-2023)
Table 98. Global Influenza Vaccine Sales Market Share by Application (2024-2029)
Table 99. Global Influenza Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 100. Global Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 101. Global Influenza Vaccine Revenue Market Share by Application (2018-2023)
Table 102. Global Influenza Vaccine Revenue Market Share by Application (2024-2029)
Table 103. Global Influenza Vaccine Price by Application (2018-2023) & (USD/Doses)
Table 104. Global Influenza Vaccine Price by Application (2024-2029) & (USD/Doses)
Table 105. Key Raw Materials
Table 106. Raw Materials Key Suppliers
Table 107. Influenza Vaccine Distributors List
Table 108. Influenza Vaccine Customers List
Table 109. Influenza Vaccine Industry Trends
Table 110. Influenza Vaccine Industry Drivers
Table 111. Influenza Vaccine Industry Restraints
Table 112. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Influenza VaccineProduct Picture
Figure 5. Global Influenza Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Influenza Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Influenza Vaccine Sales (2018-2029) & (M Doses)
Figure 8. Global Influenza Vaccine Average Price (USD/Doses) & (2018-2029)
Figure 9. Trivalent Influenza Vaccine Product Picture
Figure 10. Quadrivalent Influenza Vaccine Product Picture
Figure 11. For Children (6 months to 3 years) Product Picture
Figure 12. For Adults and Children over 3 years Product Picture
Figure 13. Global Influenza Vaccine Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of Influenza Vaccine, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of Influenza Vaccine, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 Influenza Vaccine Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global Influenza Vaccine Sales by Region in 2022
Figure 20. Global Influenza Vaccine Revenue by Region in 2022
Figure 21. North America Influenza Vaccine Market Size by Country in 2022
Figure 22. North America Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 23. North America Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Influenza Vaccine Market Size by Country in 2022
Figure 27. Europe Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 28. Europe Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 29. Germany Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Influenza Vaccine Market Size by Country in 2022
Figure 35. Asia Pacific Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 37. China Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Influenza Vaccine Market Size by Country in 2022
Figure 47. Latin America Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Latin America Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East and Africa Influenza Vaccine Market Size by Country in 2022
Figure 53. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 54. Middle East and Africa Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Global Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Global Influenza Vaccine Price (USD/Doses) by Type (2018-2029)
Figure 61. Global Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 62. Global Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 63. Global Influenza Vaccine Price (USD/Doses) by Application (2018-2029)
Figure 64. Influenza Vaccine Value Chain
Figure 65. Influenza Vaccine Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Influenza Vaccine Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings